Cenyx Biotech
Seoul
About Cenyx Biotech
Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2026)
- Website: cenyxbiotech.com
- Phone: +82 2 741 6110
Industries & Categories
Health Diagnostics, Nanotechnology, Therapeutics
Canonical: https://fsome.com/organization/cenyx-biotech-90767 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.